References
- Sikorska B, Liberski PP. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease. Subcell Biochem. 2012;65:457-96. doi: 10.1007/978-94-007-5416-4_17.
- Sitammagari KK, Masood W. Creutzfeldt Jakob Disease [lnternet]. StatPearls, National Library of Medicine. Available at: www.ncbi.nlm.nih.gov/books/NBK507860/ Accessed June 21, 2024.
- Green AJE, Thompson EJ, Stewart GE, et al. Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery and Psychiatry. 2001;70(6):744–748. doi: 10.1136/jnnp.70.6.744.
- Green AJE. RT-QulC: a new test for sporadic CJD. Pract Neurol. 2019 Feb;19(1):49-55. doi: 10.1136/practneurol-2018-001935.
- Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006 May;117(5):935-51. doi: 10.1016/j.clinph.2005.12.007.
- Center of Disease Control. Clinical Overview of Creutzfeldt-Jakob Disease (CJD) [lnternet]. Available at: www.cdc.gov/creutzfeldt-jakob/hcp/clinical-overview/index.html. Assessed June 15, 2024.
- Heinemann U, Krasnianski A, Meissner B, et al. Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg. 2008 Oct;109(4):735-41. doi: 10.3171/JNS/2008/109/10/0735.
- Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021 Mar;20(3):235-246. doi: 10.1016/S1474-4422(20)30477-4. Erratum in: Lancet Neurol. 2021 Apr;20(4):e3. doi: 10.1016/S1474-4422(21)00069-7.).
- Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021 Mar;20(3):235-246. doi: 10.1016/S1474-4422(20)30477-4.
- Steinhoff BJ, Zerr l, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004 Nov;56(5):702-8. doi: 10.1002/ana.20261.
